Browse 24950 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 7th, 2022 |
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) |
National Institutes of Health |
July 26th, 2019 |
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional) |
National Institutes of Health |
July 26th, 2019 |
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) |
National Institutes of Health |
July 26th, 2019 |
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional) |
National Institutes of Health |
July 26th, 2019 |
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional) |
National Institutes of Health |
June 2nd, 2020 |
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) |
National Institutes of Health |
June 27th, 2019 |
Medical Rehabilitation Research Resource (P2C Clinical Trial Optional) |
National Institutes of Health |
April 13th, 2019 |
Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships |
Zambia USAID Lusaka |
April 18th, 2019 |
Karabo ea Bophelo (KB) Activity in Lesotho |
South Africa USAID Pretoria |
July 1st, 2021 |
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
October 18th, 2020 |
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) |
National Institutes of Health |
February 16th, 2022 |
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 21st, 2021 |
Maximizing Access to Research Careers (T34) |
National Institutes of Health |
May 21st, 2021 |
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) |
National Institutes of Health |
May 13th, 2019 |
Administrative Supplement for Research on Bioethical Issues |
National Institutes of Health |
March 29th, 2019 |
USAID Burundi Gender Based Violence (GBV) Activity |
Rwanda USAID Kigali |
March 29th, 2019 |
USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity |
Rwanda USAID Kigali |
May 20th, 2019 |
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial |
National Institutes of Health |
October 1st, 2019 |
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 20th, 2019 |
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center |
National Institutes of Health |
|
June 11th, 2019 |
Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
April 2nd, 2019 |
Request for Information(RFI) |
Mali USAID Bamako |
August 6th, 2019 |
Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
October 1st, 2019 |
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
May 28th, 2021 |
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
May 15th, 2019 |
Good Health and Wellness in Indian Country |
Centers for Disease Control NCCDPHP |
April 8th, 2019 |
Eliminate Tuberculosis in Ethiopia (ETBE) |
Ethiopia USAID Addis Ababa |
May 15th, 2019 |
Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 21st, 2022 |
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
March 23rd, 2022 |
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
National Institutes of Health |
March 23rd, 2022 |
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
National Institutes of Health |
May 6th, 2019 |
First Responders-Comprehensive Addiction and Recovery Act |
Substance Abuse and Mental Health Services Adminis |
May 6th, 2019 |
Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
July 31st, 2019 |
Technical Assistance for Response to Public Health or Healthcare Crises: OPIOID SUPPLEMENTAL |
Centers for Disease Control OSTLTS |
May 7th, 2022 |
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 2nd, 2019 |
FY 2019 AmeriCorps Indian Tribes Grants |
Corporation for National and Community Service |
May 26th, 2021 |
NINDS Institutional Research Training Program (T32) |
National Institutes of Health |
June 14th, 2019 |
Technical Assistance for Response to Public Health or Healthcare Crises: HURRICANE SUPPLEMENTAL |
Centers for Disease Control OSTLTS |
May 6th, 2019 |
Newborn Screening State Evaluation Program |
Health Resources and Services Administration |
June 28th, 2019 |
Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |